Read + Share
Amedeo Smart
Independent Medical Education
Munakata W, Kumode T, Goto H, Fukuhara N, et al. A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 study. Br J Haematol 2025 Jan 8. doi: 10.1111/bjh.19994.PMID: 39778876
Email
LinkedIn
Privacy Policy